NASDAQ •
Healthcare •
Medical Instruments & Supplies •
Quote as of 05/21/2026 16:00
Company Profile
IndustryMedical Instruments & Supplies
SectorHealthcare
ExchangeNASDAQ
Market Capitalization13.03 mln
Float10.30 mln
Earnings Date08/13/2026
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-3.71
Highly reliable
1-Year Forecast
5.00
Transformational upside
Relative Strength
16
/ 100
Significantly lagging
Debt / Equity
0.16
Very low leverage
ROE
-59.14
Deeply negative
Business Description
Bionano Genomics is a San Diego-based company founded in 2003 that operates globally across the Americas, Europe, the Middle East, Africa, and Asia Pacific. The company develops tools, instruments, and software that help genetics laboratories study the human genome, identify structural variations in DNA, and uncover the causes of genetic conditions. It also runs its own testing services, helping to diagnose disorders such as autism, developmental delays, Fragile X syndrome, and certain muscular diseases.
